# US 2021/0171934 A1 · Methods for isolating microvesicles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171934 A1
- Document ID: US20210171934A1
- Status: Published application
- Kind: A1
- Application number: 16/893,966
- Filed: 2020-06-05
- Published: 2021-06-10
- Earliest claimed: 2013-01-03
- Assignees: Exosome Diagnostics, Inc.
- Applicants: Exosome Diagnostics, Inc.
- Inventors: Daniel ENDERLE; Aparna RAMACHANDRAN; Haoheng YAN; Emily BERGHOFF; Tai-Fen WEI; Mikkel NOERHOLM; Johan Karl Olov SKOG
- Web page: https://patentgrep.com/patent/US20210171934A1

## CPC

- C12N 15/1017: {by filtration, e.g. using filters, frits, membranes}
- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention provides novel methods for isolating microvesicles from a biological sample and for extracting nucleic acids from the microvesicles.

## Claims

### Claim at position 1

-30. (canceled)

### Claim 31

A method for extracting nucleic acids from a biological sample comprising a microvesicles comprising:
(a) contacting the biological sample with a capture surface under conditions sufficient to retain the microvesicles on or in the capture surface, wherein the capture surface comprises three membranes that are positively charged and functionalized with quaternary ammonium;
(b) lysing the microvesicles while the microvesicles are on or in the capture surface; and
(c) extracting the nucleic acids from the eluted microvesicles.

### Claim 32 (depends on 31)

The method of claim 31, wherein the three membranes are identical to each other.

### Claim 33 (depends on 31)

The method of claim 31, wherein the three membranes are directly adjacent to each other.

### Claim 34 (depends on 31)

The method of claim 31, wherein the biological sample is plasma, serum, urine, cerebrospinal fluid or cell culture supernatant.

### Claim 35 (depends on 31)

The method of claim 31, wherein the biological sample has a volume of less than about 4 mL.

### Claim 36 (depends on 31)

The method of claim 31, wherein the biological sample has a volume of between about 0.1 to about 4 mL.

### Claim 37 (depends on 31)

The method of claim 31, wherein the biological sample has a volume of about 1 mL.

### Claim 38 (depends on 31)

The method of claim 31, wherein the extracted nucleic acids comprise mRNA, miRNA, or a combination thereof.

### Claim 39

A method for extracting nucleic acids from a biological sample comprising:
(a) contacting the biological sample with a capture surface under conditions sufficient to retain microvesicles on or in the capture surface, wherein the capture surface comprises three membranes that are positively charged and functionalized with quaternary ammonium;
(b) eluting the microvesicles from the capture surface to obtain a microvesicle fraction; and
(c) extracting the nucleic acids from the microvesicle fraction.

### Claim 40 (depends on 39)

The method of claim 39, wherein the eluted microvesicle fraction from step (b) is concentrated by a spin concentrator to obtain a concentrated microvesicle fraction, and wherein the nucleic acids are extracted from the concentrated microvesicle fraction.

### Claim 41 (depends on 39)

The method of claim 39, wherein the three membranes are identical to each other.

### Claim 42 (depends on 39)

The method of claim 39, wherein the three membranes are directly adjacent to each other.

### Claim 43 (depends on 39)

The method of claim 39, wherein the biological sample is plasma, serum, urine, cerebrospinal fluid or cell culture supernatant.

### Claim 44 (depends on 39)

The method of claim 39, wherein the biological sample has a volume of less than about 4 mL.

### Claim 45 (depends on 39)

The method of claim 39, wherein the biological sample has a volume of between about 0.1 to about 4 mL.

### Claim 46 (depends on 39)

The method of claim 39, wherein the biological sample has a volume of about 1 mL.

### Claim 47

A kit comprising a:
a) a capture surface comprising three membranes that are positively charged and functionalized with quaternary ammonium;
b) at least one nucleic acid amplification primer, wherein the at least one nucleic acid amplification primer comprises at least one sequence selected from SEQ ID NOs: 1-10.

### Claim 48 (depends on 47)

The kit of claim 47, wherein the at least one nucleic acid amplification primer comprises SEQ ID NO: 1.

### Claim 49 (depends on 47)

The kit of claim 47, wherein the at least one nucleic acid amplification primer comprises SEQ ID NO: 2.

### Claim 50 (depends on 47)

The kit of claim 47, further comprising a lysis buffer.
